• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    January AI Raises $8.8 Million in New Funding

    FDA Clears Ava Fertility Tracking Wearable Device

    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

    Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

    Japan to Lead APAC Assisted Reproductive Technology Devices Market
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Spectrum Plastics Group

    FUTEK Advanced Sensor Technology Inc.

    K-Tube Technologies

    Medicoil

    Medbio LLC
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services

    The 8 Major Types of PPE Supply Chain Fraud
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Spectrum Plastics Group

    Concise Engineering

    Forefront Medical Technology

    Medicoil

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Medtronic-Covidien Merger—A Post-Mortem Analysis

    ...

    The Medtronic-Covidien Merger—A Post-Mortem Analysis
    Related CONTENT
    • Mike on Medtech: Update on FDA's STeP Designation
    • First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    • Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    • Refurbished Medical Equipment Testing and Certification Under the NEC
    • Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification
    Bryan Hughes, P&M Corporate Finance07.20.16
    For much of the past decade, medical device companies have reshaped their businesses through acquisitions, divestitures, and portfolio realignment. As the realities of the Affordable Care Act, payer and provider consolidation, and continued pricing pressure (along with other headwinds) have become more transparent, medical device firms have sought to offset declining growth through multiple non-organic means. No event over the last two years illustrates the rationale and downstream consequences of this strategy quite as acutely as Medtronic plc’s acquisition of Covidien. On an otherwise quiet summer weekend in 2014, the two companies shocked the medical device community by announcing a $42.9 billion merger.

    The mere size of the transaction moved Medtronic up two spots on Medical Product Outsourcing’s annual ranking of the 30 largest medical device companies, surpassing both GE and Siemens. The company now trails only Johnson & Johnson, itself transformed through multiple acquisitions and divestitures, in the most recent ranking. 
    Industry analysts applauded the Covidien transaction, which built upon three key tenets—therapy innovation, globalization, and economic value. In prepared remarks, Covidien’s then CEO Joe Almeida stated, “Covidien and Medtronic, when combined, will provide patients, physicians, and hospitals with a compelling portfolio of offerings that will help improve care and surgical performance. This transaction provides our shareholders with immediate value and the opportunity to participate in the significant upside potential of the combined organization.” 

    Much of this promise has proven out; the transaction truly was transformational, affording shareholders the value upside from the significant strategic synergies the deal creates. On a combined basis, the company now has a dozen billion-dollar-plus franchises, an amazing accomplishment, considering Covidien and Medtronic were surprisingly non-competitive with limited product overlap as standalone businesses. As important, however, the deal brought together very complementary approaches and philosophies toward end markets, research and development, and global markets. The much larger Medtronic has grown its revenue to more than $28 billion over the last two years, while its share price has increased 37.5 percent over the same time period.  On a relative basis, the S&P 500 squeaked out a mere 6.3 percent gain during that time. 

    As is the case with many other large transactions across all industries, Medtronic made the valuation it placed on Covidien work, in part, through setting aggressive synergy targets. The two companies outlined more than $850 million in annual savings to be fully achieved by the end of Medtronic’s 2018 fiscal year. This transaction is in no way unique in its pursuit of such a high level of cost-savings from the combined entities; whether from a seller or buyer perspective, the mention of specific transaction synergies is almost always mentioned in describing the transaction. Sometimes cost synergies can make a deal work financially; often, they are the strategic justification for pulling the trigger—the classic one plus one equals something greater than two. In medical technology transactions, operational synergies are pervasive, and their impact on the medical product outsourcing universe is real. Over the course of 2014 and 2015, PMCF sampled nine transactions that collectively were expected to generate more than $2.1 billion in cost synergies.

    Medtronic/Covidien $850M
    Thermo Fisher/Life Technologies $350M
    Zimmer/Biomet $350M
    Becton Dickinson/CareFusion $250M
    Cardinal Health/Cordis Corp. $100M
    Smith & Nephew/ArthroCare $85M
    Cyberonics/Sorin Group $80M
    Hill-Rom Holdings/Welch Allyn $40M
    Tornier N.V./Wright Medical $45M










    In each transaction, the specific language used to describe the areas of expected cost savings became a bit blurred. However, from back-office redundancies and facility optimization to a shift to lower cost regions, all functional areas have been outlined as opportunities to achieve meaningful transaction synergies. Often, operations and the supply base absorb the largest impact of these efforts. In translating the combined $2.1 billion of cost savings into relative terms, it represents only 7 percent of the combined cost of goods sold (COGS) of the sampled companies. But when compared to estimates of “outsourced” spending, which is where we would expect operational synergies to hit hardest, that number increases to 25 percent.

    While the entire $2.1 billion is obviously not going to come entirely from the supply chain, in a vacuum, any meaningful percentage of that number would dramatically slow growth in the outsourcing market.  As certain commodities are consolidated, and redundant suppliers are “optimized,” we believe the market will begin to experience an increased level of transaction activity among the supply base. Even the strongest companies will pursue acquisitions to gain scale, extend capabilities and geographic footprint, and provide higher value services.

    During Medtronic’s recent 2016 Investor Day held in New York City, Chief Financial Officer Gary Ellis outlined the company’s success in achieving its synergy target. Through the end of FY16 (ended April 29), Medtronic had realized more than $350 million in savings, with approximately $250 million in additional savings targeted in fiscal 2017 and 2018 respectively. Because of the limited product overlap between Medtronic and Covidien, only a small portion of this number—approximately $60 million—resulted from commercial activities, in this case the integration of similar peripheral vascular franchises.  At the same time, SG&A expenses are expected to fall by approximately $420 million, including multiple redundancies in back office and other support functions, as well as the consolidation of more than 100 non-operations facilities globally.

    Perhaps most relevant to the medical product outsourcing industry, supply chain and sourcing optimization synergies are expected to contribute an additional $370 million. These savings are coming from shared supplier rationalization, freight reductions through common contracts, value engineering, and an integrated transportation, logistics, and distribution footprint. Unfortunately for suppliers to the medical device industry, the long-term impact of these synergy numbers may only be the tip of the iceberg. 

    At the MPO Summit held last fall in Park City, Utah, I spoke on the parallels between the consolidation and purchasing pressure seen today in the medical device market and the experiences of automotive and aerospace industries 15 to 20 years ago. In 1998, following its acquisitions of McDonnel Douglass and Rockwell Collins, Boeing outlined an aggressive post-merger integration strategy to radically transform both how it manufactured commercial airplanes, and what the associated supply chain would look like. 

    The stated goal was that within four years, the company would cut 13,000 suppliers from its ranks. Once this effort gained momentum within the company’s Seattle, Wash., headquarters, though, cost-cutting targets ballooned and accelerated. By 2005, Boeing had moved its headquarters to Chicago, Ill., and had reduced its supply chain by nearly 24,000 suppliers—almost 80 percent of its 1998 base.

    At the Summit, I proposed the idea that much like the experience of aerospace before, recent medical device transactions would trigger a much higher level of supplier consolidation than had been detailed in the aforementioned synergy targets. The prediction was based on the view that once integration consultants started digging into enough supply chain data to make a mere mortal’s head spin, it would create an environment for supplier rationalization well beyond what would be expected by the synergy targets. Depending on how cynical you are, once consultants start analyzing the data, it can often provide company executives either the strategic business case or the excuse to pursue such sweeping cost-saving initiatives.

    While non-operational facility consolidation was targeted for more than $100 million in savings, optimization of Medtronic’s manufacturing plant network was estimated to initially generate just $5 million in cost savings following the Covidien acquisition. However, by the June 2016 Investor Day, the targeted cost savings from Medtronic’s manufacturing plant optimization had increased to more than $500 million. With echoes of Boeing in the late 1990s, in the same investor presentation, Medtronic characterized the Covidien synergies as the “catalyst for a long tail of leverage opportunities beyond FY18.”

    Including the initial $850 million in synergies related to the Covidien acquisition, [through 2021, Medtronic now expects to cut SG&A expenses by $1.7 billion and COGS by more than $3 billion]. If successful, and accounting for the downward pressure from other items, this effort will generate an operating margin improvement of more than 650 basis points over this time period. While the SG&A leverage target and strategy is quite interesting, the pure scale of the COGS reduction targets and the potential impact on the broader medical product supply chain warrants a closer examination.
    • Manufacturing plant optimization target of $500 million. Of its roughly 90 manufacturing sites, Medtronic expects it may reduce that number to 50. Manufacturing will be focused around a smaller number of strategic locations, and the company will support the development of local-for-local manufacturing, particularly where there is a strong local preference or the ability to leverage government support.
    • Lean manufacturing and cell operating system target of $1.2 billion. Much of this savings is expected to result from the implementation of the Medtronic Operating System across the organization.
    • Sourcing target of $1.2 billion. To put this number in perspective, $1.2 billion would represent over 50 percent of many estimates of Medtronic’s outsourced spend. The key focus areas of this initiative are outlined as renegotiation of supplier agreements and identification of alternative supply sources. Coupled with the local-for-local initiative outlined previously, this effort will likely result in a dramatic reduction in the size of Medtronic’s supply base, with new sourcing focused on larger suppliers with truly global capabilities.
    • Design for Manufacturability target of $100 million. Savings will be driven by value engineering and supplier collaboration for design for manufacturability.
    • Medtronic’s acquisition of Covidien certainly was not the first transaction to reshape the medical device landscape, and it won’t be the last. In fact, in late April of this year, Abbott announced its $25 billion acquisition of St. Jude Medical Inc. in a deal the two companies claimed will create “a premier medical device leader.”  In that instance, transaction synergies are estimated at over $500 million. 
    Once that transaction closes, five companies listed in the 2013 edition of the MPO Top 30—Covidien, St. Jude Medical, Hospira Inc., CareFusion, and Biomet—will have been acquired by larger medical device players. Multiple companies listed in this year’s Top 30 are likely to be acquisition targets themselves over the next several years. The key question for participants in the medical product outsourcing industry is, whether we are best positioned as these end market transactions continue to reshape the supply chain. 


    Bryan Hughes is a director of PMCF and leads the firm’s medical technology team. His practice focuses on assisting clients with M&A, leveraged buyouts, private placements, financings, valuation, and strategic consulting. His clients have ranged from global medtech companies to small, privately held businesses. Hughes also has completed transactions in the business services, consumer, and industrial sectors. He has written numerous articles and is a frequent speaker on healthcare investment banking topics. 
    Related Searches
    • cardinal health
    • medical technology
    • development
    • siemens
    Related Knowledge Center
    • Contract Manufacturing
    • R&D & Design
    Suggested For You
    Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid
    Mike on Medtech: Update on FDA Mike on Medtech: Update on FDA's STeP Designation
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    Refurbished Medical Equipment Testing and Certification Under the NEC Refurbished Medical Equipment Testing and Certification Under the NEC
    Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification
    FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump
    Millstone Medical Outsourcing Reaches 600-Employee Milestone Millstone Medical Outsourcing Reaches 600-Employee Milestone
    Apple iPhone 12 Magnet Can Deactivate Implantable Cardiac Devices Apple iPhone 12 Magnet Can Deactivate Implantable Cardiac Devices
    SteriPack Acquires HS Design SteriPack Acquires HS Design
    Navient Receives Chinese Regulatory Clearance for ENT Applications Navient Receives Chinese Regulatory Clearance for ENT Applications
    Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020 Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020
    Trademark Plastics Inc. Partners with MedAccred Trademark Plastics Inc. Partners with MedAccred
    Medtronic Receives FDA Approval for Expanded MRI Labeling Medtronic Receives FDA Approval for Expanded MRI Labeling
    Bicuspid Aortic Stenosis Treatment to Create Huge Market Potential for TAVR Devices Bicuspid Aortic Stenosis Treatment to Create Huge Market Potential for TAVR Devices

    Related Columns

    • R&D & Design
      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, President & Founder, Empirical 02.03.21

    • Contract Manufacturing
      Use Vertical Integration to Increase Productivity, Drive Innovation

      Use Vertical Integration to Increase Productivity, Drive Innovation

      The concept of vertical integration is simple: a company combining two or more stages of production that would normally be operated by separate companies.
      Ryan Lipe, Senior Vice President of Sales & Marketing, MGS 02.03.21

    • Contract Manufacturing
      So Many Changes in Medtech, So Short a Time

      So Many Changes in Medtech, So Short a Time

      This article looks at the general state of medtech/life sciences M&A and the outsourcing trends triggered by the worldwide COVID-19 pandemic.
      Mark Bonifacio, President, BCS LLC 10.01.20


    • Contract Manufacturing | R&D & Design
      Trends for Medtech Contract R&D and Manufacturing

      Trends for Medtech Contract R&D and Manufacturing

      Over the past 10 years, medtech manufacturers from startups to giants have grown their levels of outsourcing to contract R&D and manufacturing partners.
      Maria Shepherd, President and Founder, Medi-Vantage 09.01.20

    • Contract Manufacturing
      Smart Sourcing: Transforming the Supply Chain Into a Value Network

      Smart Sourcing: Transforming the Supply Chain Into a Value Network

      The rise of globalization and outsourcing has led to increased supply chain risk and decreased predictability due to variability and complexity.
      Daniel R. Matlis and Sandra K. Rodriguez, Axendia Inc. 09.01.20

    • R&D & Design | Surgical
      Sparking Innovation as We Struggle to Find the New Normal

      Sparking Innovation as We Struggle to Find the New Normal

      The goal is to find the best ideas to support orthopedic patients adjusting to additional pain and immobility while they wait for elective surgeries.
      Dawn A. Lissy, Founder & President, Empirical 06.04.20


    • Contract Manufacturing
      Shopping Smart: What to Look for in a Contract Manufacturer

      Shopping Smart: What to Look for in a Contract Manufacturer

      A contract manufacturing organization can help shoulder the workload of bringing a new device to market.
      Claudio Hanna and Jennifer Ponti, Web Industries Inc. 06.04.20

    • R&D & Design
      Disposable Design: Consider All Interfaces

      Disposable Design: Consider All Interfaces

      The disposable component is becoming more challenging as products get smaller and more complex.
      Will DeMore, Mechanical Engineer, Key Technologies Inc. 06.04.20

    • R&D & Design
      Why Outsourcing Is in: Piecing Out Projects Makes Sense

      Why Outsourcing Is in: Piecing Out Projects Makes Sense

      Getting outside help is a trend both large and small medical device companies are following as outsourcing engineering services continues to gain traction.
      Dawn A. Lissy, President & Founder, Empirical 04.01.20


    • R&D & Design
      Top 10 Considerations for Medtech Inventors

      Top 10 Considerations for Medtech Inventors

      If you or your employer is interested in protecting an invention, then filing a patent application may be the way to go.
      Ryan Connell and Doug Portnow, Schwegman Lundberg & Woessner 04.01.20

    • R&D & Design
      Supercharge Medical Device Innovation Using Effective User Preference Studies

      Supercharge Medical Device Innovation Using Effective User Preference Studies

      User preference and evaluation studies have been a mainstay design tool for medical device development for decades.
      Philip Remedios, Principal, Director of Design & Development, BlackHägen Design 04.01.20

    • Contract Manufacturing
      A Valuable Supply Chain Lesson, Courtesy of Coronavirus

      A Valuable Supply Chain Lesson, Courtesy of Coronavirus

      The deadly respiratory disease spreading like wildfire around the world is exposing major weaknesses in the global medtech supply chain.
      Michael Barbella, Managing Editor 03.04.20


    • Contract Manufacturing
      The Seychelles—A Solution for Niche Production

      The Seychelles—A Solution for Niche Production

      Geographic location, free trade agreements, and an educated workforce make the location an excellent fit for the right manufacturer.
      Jude Shroff, Managing Director, Chelle Medical Ltd. 03.04.20

    • Contract Manufacturing
      Supply Chain Risk Monitoring: Playing 20 Questions

      Supply Chain Risk Monitoring: Playing 20 Questions

      Whether an earthquake or the spread of the coronavirus, recent incidents highlight the reality and complexity associated with managing a global supply chain.
      Ryan Oleksy, Co-Founder, Next Life Medical Corporation; Advisor, Sauron Group 03.04.20

    • Contract Manufacturing
      How Medical Product Outsourcers Can Compete on Quality in 2020

      How Medical Product Outsourcers Can Compete on Quality in 2020

      Outsource firms are reshaping medical device manufacturing as nearly every leading OEM turns to them to effectively compete on time-to-market and pricing.
      Louis Columbus, Principal, IQMS 01.29.20


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • TransEnterix Changes Name To Asensus Surgical
    • An Analysis Of The Smart Inhalers Market
    Breaking News
    • January AI Raises $8.8 Million in New Funding
    • FDA Clears Ava Fertility Tracking Wearable Device
    • First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    • Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    • Japan to Lead APAC Assisted Reproductive Technology Devices Market
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    GUM Recalls Oral Spray
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login